Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
13.00B | 12.88B | 11.92B | 12.70B | 11.60B | Gross Profit |
4.00B | 4.09B | 3.70B | 4.09B | 3.47B | EBIT |
784.83M | 965.06M | 605.13M | 823.08M | 308.00M | EBITDA |
1.39B | 1.77B | 1.47B | 1.40B | 802.00M | Net Income Common Stockholders |
584.08M | 748.24M | 589.11M | 651.05M | 265.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.63B | 1.63B | 1.35B | 1.53B | 1.50B | Total Assets |
16.10B | 15.20B | 14.32B | 13.98B | 12.16B | Total Debt |
3.12B | 3.13B | 3.36B | 3.45B | 2.97B | Net Debt |
1.49B | 1.50B | 2.01B | 1.92B | 2.29B | Total Liabilities |
7.81B | 7.85B | 7.83B | 8.37B | 7.29B | Stockholders Equity |
8.28B | 7.35B | 6.50B | 5.62B | 4.86B |
Cash Flow | Free Cash Flow | |||
126.19M | 573.95M | -7.55M | -349.35M | 437.00M | Operating Cash Flow |
966.39M | 1.12B | 490.66M | 762.84M | 978.00M | Investing Cash Flow |
-838.81M | -643.92M | -496.46M | -1.13B | -599.00M | Financing Cash Flow |
-125.72M | -299.93M | -173.66M | 399.23M | -236.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥841.37B | 16.99 | 10.76% | 1.77% | 4.49% | -33.80% | |
73 Outperform | ¥3.49T | 23.65 | 2.54% | 0.23% | 12.16% | ||
71 Outperform | ¥5.46B | 7.94 | 1.95% | 10.30% | 69.33% | ||
71 Outperform | $940.63B | 9.80 | 25.48% | 2.77% | 30.34% | 55.11% | |
68 Neutral | ¥419.75B | 20.56 | 6.33% | 2.96% | -8.53% | -49.42% | |
66 Neutral | ¥853.65B | 114.83 | 0.98% | 2.29% | -6.57% | -76.15% | |
52 Neutral | $5.35B | 3.81 | -42.57% | 2.86% | 17.10% | 1.33% |